Table 1.

Clinical Characteristic of the Study Cohort:

	SJYC07	NPTP	Entire Cohort
	N = 41	N = 15	N = 56
Age on Study
< 3 years	41 (100%)	8 (53%)	49 (88%)
3–5 years	0 (0%)	7 (47%)	7 (12%)
Gender
Male	27 (67%)	5 (33%)	32 (57%)
Female	14 (33%)	10 (67%)	24 (43%)
Histology at Diagnosis
HGG	41 (100%)	15 (100%)	56 (100%)
Metastatic Status
Nonmetastatic (M0)	36 (88%)	13 (87%)	49 (88%)
Metastatic (M+)	5 (12%)	2 (13%)	7 (12%)
Tumor Location
Hemispheric	29 (71%)	12 (80%)	41 (73%)
Midline	8 (19%)	3 (20%)	11 (20%)
Cerebellum	4 (10%)	0 (0%)	4 (7%)
Extent of Resection
GTR	21 (51%)	7 (47%)	28 (50%)
NTR	4 (10%)	1 (6%)	5 (9%)
STR	8 (20%)	3 (20%)	11 (20%)
Biopsy	8 (20%)	4 (27%)	12 (21%)
Treatment Risk group
SJYC07-Low Risk/NPTP-Low Like	36 (88%)	6 (40%)	42 (75%)
SJYC07-High Risk/NPTP-High Like	5 (12%)	2 (13%)	5 (9%)
NPTP-Others	0 (0%)	7 (47%)	7 (12%)
Total	41 (73%)	15 (27%)	56 (100%)